Abbott’s Covid-19 Antigen Test May Help with Faster Detection, Isolation, Per the CDC
A study from the CDC found that BinaxNOW catches most infectious cases but may miss nearly two-thirds of covid-19 infections in people without symptoms.
Read MorePosted by Laurie Bonner | Jan 26, 2021 | Covid 19, POC Rapid Assays |
A study from the CDC found that BinaxNOW catches most infectious cases but may miss nearly two-thirds of covid-19 infections in people without symptoms.
Read MorePosted by Melanie Hamilton-Basich | Jan 25, 2021 | Research, Sepsis |
The UT Dallas researchers’ sensor is a portable device that monitors a panel of five immune biomarkers using only a single drop of blood plasma, making a sepsis diagnosis available within minutes.
Read MorePosted by Melanie Hamilton-Basich | Jan 20, 2021 | Company News, Point-of-Care |
“Mesa Biotech’s innovative platform will enable us to accelerate the availability of reliable and accurate advanced molecular diagnostics at the point of care,” says Thermo Fisher Scientific’s Mark Stevenson.
Read MorePosted by Melanie Hamilton-Basich | Jan 12, 2021 | Covid 19, Flu & Respiratory Infections, POC Rapid Assays |
QuantuMDx expects to achieve CE-IVD marking for its Q-POC system in early 2021, following a release for research use only.
Read MorePosted by Laurie Bonner | Jan 8, 2021 | Covid 19, POC Reagents & Test Kits |
The self-administered, noninvasive saliva kits are FDA authorized for use by both individuals with and without symptoms of covid-19.
Read More